Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Insulin Resistance × Canagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Non-alcoholic Fatty Liver Disease 1 Insulin Resistance 1

Interventions

Metformin 6 Pioglitazone 3 drospirenone and ethinyl estradiol combination 1 Sugars 1 Sodium-Glucose Transporter 2 Inhibitors 1 Sitagliptin Phosphate 1 Simvastatin 1 Leuprolide 1 Insulin Glargine 1 Insulin 1 Injections 1 Fenofibrate 1 Estrogens 1 DNA, Ribosomal 1 Continuous Positive Airway Pressure 1 Canagliflozin 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡